Статус: | Recruiting |
Фаза: | N/A |
Начало: | 1 мая 2018 г. |
Окончание: | 31 августа 2024 г. |
Описание: | This exploratory study aims to assess the efficacy, safety of the experimental treatment based on a combination of rituximab (RTX), intravenous (IV) cyclophosphamide (CYC), and corticosteroids (S) administrated at lower cumulative doses (RCP) for the induction of early remission in subjects with anti-PLA2R antibody-positive primary membranous nephropathy (PMN) having nephrotic syndrome (NS). |
смотреть на ClinicalTrials.gov |
Статус: | Recruiting |
Фаза: | N/A |
Начало: | 10 марта 2013 г. |
Окончание: | 10 декабря 2027 г. |
Описание: | The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephropathy. |
смотреть на ClinicalTrials.gov |